University of Oxford: COVID-19 trials
The registry lists 16 COVID-19 studies with University of Oxford as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 4Phase 3 3No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity of COVID-19 Vaccines in Tuberculosis PatientsRecruitingNCT05571735
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingNCT05041907Phase 2
- Randomised Evaluation of COVID-19 TherapyRecruitingNCT04381936Phase 3
- COVID-19 Omicron BA.5 Subvariant Dose Finding Infection StudyActive, not recruitingNCT06478420Phase 1
- Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant CommunityCompletedNCT05557513Not applicable
- Sedation, ANalgesia and Delirium MANagement in Intensive Care UnitCompletedNCT05027217
- Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and WalesActive, not recruitingNCT04838106
- Rational Use of Personal Protective Equipment During COVID-19 PandemicCompletedNCT04712045Not applicable
- Remote-by-Default Care in the COVID-19 PandemicCompletedNCT04435041
- STerOids in COVID-19 StudyTerminatedNCT04416399Phase 2
- Investigating a Vaccine Against COVID-19CompletedNCT04400838Phase 2/3
- Neonatal Complications of Coronavirus Disease (COVID-19)Status unknownNCT04386109
- A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)CompletedNCT04381962Phase 3
- A Study of a Candidate COVID-19 Vaccine (COV001)CompletedNCT04324606Phase 1/2
- Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare SettingCompletedNCT04303507Not applicable
- Sero-epidemiological Survey of England in 2019/2020 - COVID-19CompletedNCT04061382